News – Page 1016 – Endpoints News

Allied with Roche and AstraZeneca, 4D Molecular bags $90M round for its gene therapy pipeline work

7 years ago

PhaseBio raises $34M to test orphan disease strategy — focusing first on AstraZeneca drug

7 years ago

Eyeing an IPO, Fulcrum execs nail down an $80M round on the way to the clinic with their first gene-regulating drug

7 years ago

Partnering with Amgen vet Sean Harper, veteran VC Beth Seidenberg unveils a $320M fund and a unique focus on…wait ...

7 years ago

Once a blockbuster-to-be, Teva finally sounds taps for its PhIII loser laquinimod

7 years ago

David Schenkein is passing the reins at Agios to Jackie Fouse after a star-making 10-year run

7 years ago

Brainstorm recruits Novartis vet Araya as chief commercial officer; Roche out-licenses IPF drug to Shanghai's Ark

7 years ago

Sanofi reaps first fruit of Ablynx buyout with a European OK for its lead rare disease drug

7 years ago

Another Shkreli-like drug price controversy? Leadiant finds itself in the spotlight after 500-fold price hike — FT

7 years ago

New report re-ignites fresh buzz that Bayer is prepping an R&D overhaul and job cuts

7 years ago

Struggling MannKind sees shares rocket up on $105M-plus alliance with United on inhaled treprostinil

7 years ago

The high-roller club in biopharma: Who’s paying top-dollar for upfronts? And who are the busiest players at the ...

7 years ago

Oxford spinout Evox grabs a $45M bankroll to advance to the clinic with new exosome tech

7 years ago

Illustrious Cambridge scientists join forces with $129M fund to bet on long plays in biotech

7 years ago

GlaxoSmithKline scientist cops a guilty plea in scheme to sell the pharma giant's drug research in China

7 years ago

Editas CMO to exit as CRISPR tech gears up; Roche diagnostics division CEO Roland Diggelmann is out

7 years ago

China regulators launch a review for BeiGene’s PD-1; PureTech co-founder hops to Longwood Fund

7 years ago

Once charged with speeding up Eli Lilly’s slow-mo R&D group, Anne White is handed the reins at Lilly Oncology

7 years ago

Coming to America: Rehan Verjee jumps up to top US healthcare post for Merck KGaA in high-level revamp

7 years ago

Looking to retain its runner-up position in HIV, Merck scores two new approvals for HIV therapies

7 years ago

Qiming, Hillhouse bet on Jacobio's nascent pipeline of first-in-class drug hopefuls in $55M round

7 years ago

In latest setback, AstraZeneca’s high hopes for its lupus drug anifrolumab crushed by a PhIII failure

7 years ago

Allied with Genentech and Pfizer on discovery deals, protein degradation crew at Arvinas looks for $100M IPO ahead of ...

7 years ago

As R&D setbacks multiply, a pioneering CRISPR/Cas9 program for Duchenne MD continues to impress in new dog study

7 years ago

First page Previous page 1013 1014 101510161017 1018 1019 Next page Last page